ICICI Securities recommended reduce rating on GlaxoSmithKline Pharmaceuticals with a target price of Rs 2,600 in its research ...

British pharmaceutical giant GlaxoSmithKline announced Wednesday the acquisition of a drug under development to treat a ...

Drugmaker GSK (GlaxoSmithKline) has said it is “well positioned” to cope with any financial impact from changes to US tariff rules. It came as the FTSE 100 giant revealed a rise in sales as weakness ...

With the stock's current price at Rs 2819.60, GlaxoSmithKline Pharmaceuticals is navigating through market dynamics, ...

The company is working closely with the contract manufacturing facility for resumption of operations. Shares of ...

Discover the details about Andrew Witty’s life, such as his educational qualifications, career graph, major achievements, ...

UnitedHealth CEO Andrew Witty is stepping down for personal reasons and the nation’s largest health insurer suspended its ...

GlaxoSmithKline Pharmaceuticals Ltd. reported a 36% increase in consolidated net profit to Rs 263 crore for the quarter ended ...

GlaxoSmithKline Pharmaceuticals, operating in the Pharmaceuticals sector and classified as a Midcap on the BSE, currently has its share price at ₹2827.05. The stock has experienced fluctuations ...

Looking at the universe of stocks we cover at Dividend Channel, on 5/16/25, Coca-Cola Europacific Partners plc (Symbol: CCEP), Smurfit Westrock plc (Symbol: SW), and Glaxosmithkline plc (Symbol ...

Todays focus will be on GSK Pharma shares in light of the companys announced topline growth and profitability for the full ...

NBCC: The company has successfully sold 446 residential units at Aspire Silicon City in Noida through an e-auction, generating Rs 1,468 crore in sales. Additionally, it will receive a marketing fee of ...